Online first
Current issue
Archive
Special Issues
About the Journal
Publication Ethics
4/2021 vol. 28
Stats
CC BY-NC 3.0 Poland
Get citation
CASE REPORT
Citrobacter freundii and Acinetobacter baumanii infection in a patient with neoplastic lung disease – Case report
Marcin Lewicki 1
,
 
Małgorzata Kozioł 2
,
 
Karol Lorenc 3
,
 
Magdalena Kozioł 3
,
 
Mateusz Pawlicki 3
,
 
Agata Smoleń 1
 
 
 
More details
Hide details
1
Department of Epidemiology and Clinical Research Methodology, Medical University, Lublin, Poland
 
2
Chair and Department of Medical Microbiology, Medical University, Lublin, Poland
 
3
Student Scientific Association at Department of Epidemiology and Clinical Research Methodology, Medical University, Lublin, Poland
 
 
Corresponding author
Karol Lorenc   

Student Scientific Association at Department of Epidemiology and Clinical Research Methodology, Medical University, Radziwiłłowska 11, 20-080 Lublin, Poland
 
 
Ann Agric Environ Med. 2021;28(4):724-728
DOI: https://doi.org/10.26444/aaem/140111
 
 
Article (PDF)
References (25)
 
KEYWORDS
antibiotic resistance
antibiotic therapy
alert pathogen
 
TOPICS
Biological agents posing occupational risk in agriculture, forestry, food industry and wood industry and diseases caused by these agents (zoonoses, allergic and immunotoxic diseases)
 
ABSTRACT
An 85-year-old male with a tumour in his right lung was admitted to Internal Diseases Ward to continue treatment after suffering a sudden cardiac arrest. An empiric antibiotic therapy with amoxycillin was introduced due to increased inflammation markers. Blood and sputum were collected. An abundant growth of AmpC β-lactamase-producing Citrobacter freundii was observed in culture grown from the sputum. The antibiogram showed retained sensitivity to fluoroquinolones. The therapy was modified by replacing β-lactam with ciprofloxacin. Neither clinical nor laboratory improvement were observed. Blood culture indicated sepsis of Acinetobacter baumannii etiology. The strain was suspected of producing OXA carbapenemase (CARBA test positive), KPC (-), MBL (-). Antibiogram illustrated retained sensitivity to gentamicin and colistin with complete resistance to ciprofloxacin. Another modification in treatment was implemented and ciprofloxacin was replaced with colistin.
Citrobacter freundii and Acinetobacter baumanii infection in a patient with neoplastic lung disease – Case report. Doi: 10.26444/aaem/140111
 
REFERENCES (25)
1.
Didkowska J, Wojciechowska U, Czaderny K, et al. Nowotwory złośliwe w Polsce w 2017 roku. Krajowy Rejestr Nowotworów http://onkologia.org.pl/wp-con... (access: 2020.10.11).
Google Scholar
 
 
2.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1): 7–30. ht tps://doi.org /10.3322/caac.21590.
Google Scholar
 
 
3.
Rancic M, Ristic L, Stankovic I. Infective complications in patients with lung cancer. Med Pregl. 2010; 63: 643–647. https://doi.org/10.2298/MPNS10....
CrossRef
 
Google Scholar
 
 
4.
Ferri M, Ranucci E, Romagnoli P, Giaccone V. Antimicrobial resistance: A global emerging threat to public health systems. Crit Rev Food Sci Nutr. 2017; 57(13): 2857–2876.https://doi.org/10.1080/104083....
CrossRef
 
Google Scholar
 
 
5.
Nichols L, Saunders R, Knollmann FD. Causes of death of patients with lung cancer. Arch Pathol Lab Med. 2012; 136(12): 1552–1557.ht t ps://doi.org/10.5858/arpa.2011-0521-OA.
Google Scholar
 
 
6.
Hayat MJ, Howlader N, Reichman ME, et al. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007; 12 (1): 2 0 –37.https://doi.org/10.1634/theonc....
CrossRef
 
Google Scholar
 
 
7.
Mayo Clinic. Diseases and conditions: Lung cancer. Retrieved from https://www.mayoclinic.org/dis... (access: 2020.10.10).
Google Scholar
 
 
8.
Nikonorow E, Baraniak A, Gniadkowski M. Oporność bakterii z rodziny Enterobacteriaceae na antybiotyki β-laktamowe wynikająca z wytwarzania β-laktamaz. Post Mikrobiol. 2013; 52(3): 261–271.
Google Scholar
 
 
9.
Gniadkowski M, Żabicka D, Hryniewicz W. Rekomendacje doboru testów do oznaczania wrażliwości bakterii na antybiotyki i chemioterapeutyki 2009: Oznaczanie wrażliwości pałeczek Gram-ujemnych. Rekomendacje KORLD 2009; 1–48. http://www.korld.edu.pl/pdf/02...] (access 2020.08.10).
Google Scholar
 
 
10.
Evans BA, Amyes SG. OXA β-lactamases. Clin Microbiol Rev. 2014; 27(2): 241–263. doi: 10.1128/CMR.00117-13. https://doi.org/10.1128/CMR .0 0117-13.
CrossRef
 
Google Scholar
 
 
11.
Wong JL, Evans SE. Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management. Clin Chest Med. 2017; 38(2): 263–277. https://doi.org/10.1016/j.ccm.....
CrossRef
 
Google Scholar
 
 
12.
Mohanty S, Singhal R, Sood S, et al. Citrobacter infections in a tertiary care hospital in Northern India. J Infect. 2007; 54(1): 58–64. https://doi.org/10.1016/j.jinf....
CrossRef
 
Google Scholar
 
 
13.
Rezaei M, Akya A, Elahi A, et al. The clonal relationship among the Citrobacter freundii isolated from the main hospital in Kermanshah, west of Iran. Iran J Microbiol. 2016; 8(3): 175–180.
Google Scholar
 
 
14.
Lee CH, Lee YT, Kung CH, et al. Risk factors of community-onset urinary tract infections caused by plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae. J Microbiol Immunol Infect. 2015; 48(3): 269–275.https://doi.org/10.1016/j.jmii....
CrossRef
 
Google Scholar
 
 
15.
Zhang R, Yang L, Cai JC, et al. High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression. J Med Microbiol. 2008; 57(Pt 3): 332–337. https://doi.org/10.1099/jmm.0.....
CrossRef
 
Google Scholar
 
 
16.
Hanson ND, Sanders CC. Regulation of inducible AmpC beta-lactamase expression among Enterobacteriaceae. Curr Pharm Des. 1999; 5(11): 881–894.
Google Scholar
 
 
17.
Liu LH, Wang NY, Wu AY, et al. Citrobacter freundii bacteremia: Risk factors of mortality and prevalence of resistance genes. J Microbiol Immunol Infect. 2018; 51(4): 565–572. https://doi.org/10.1016/j.jmii....
CrossRef
 
Google Scholar
 
 
18.
Rodríguez-Baño J, Gutiérrez-Gutiérrez B, Machuca I, et al. Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae. Clin Microbiol Rev. 2018; 31(2): e00079-17. https://doi.org/10.1128/CMR.00....
CrossRef
 
Google Scholar
 
 
19.
Mohan S, Agarwal J, Srivastava R, Singh M. Observations on Citrobacter species from a tertiary care health center with special reference to multi-drug resistance and presence of CTX-M gene. Indian J Pathol Microbiol. 2014; 57(3): 439–441. https://doi.org/10.4103/0377-4....
CrossRef
 
Google Scholar
 
 
20.
Greene C, Vadlamudi G, Newton D, et al. The influence of biofilm formation and multidrug resistance on environmental survival of clinical and environmental isolates of Acinetobacter baumannii. Am J Infect Control. 2016; 44(5): e65-e71.https://doi.org/10.1016/j.ajic....
CrossRef
 
Google Scholar
 
 
21.
Michalopoulos A, Falagas ME. Treatment of Acinetobacter infections. Expert Opin Pharmacother. 2010; 11(5): 779–788.https://doi.org/10.1517/146565....
CrossRef
 
Google Scholar
 
 
22.
Demirdal T, Sari US, Nemli SA. Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii? Ann Clin Microbiol Antimicrob. 2016; 15: 11. https://doi.org/10.1186/s12941....
CrossRef
 
Google Scholar
 
 
23.
Freire MP, de Oliveira Garcia D, Garcia CP, et al. Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropenia. Clin Microbiol Infect. 2016; 22(4): 352–358.https://doi.org/10.1016/j.cmi.....
CrossRef
 
Google Scholar
 
 
24.
Asif M, Alvi IA, Rehman SU. Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist. 2018; 11: 1249–1260. https://doi.org/10.2147/IDR.S1....
CrossRef
 
Google Scholar
 
 
25.
Ballouz T, Aridi J, Afif C, et al. Risk Factors, Clinical Presentation, and Outcome of Acinetobacter baumannii Bacteremia. Front Cell Infect Microbiol. 2017; 7: 156. https://doi.org/10.3389/fcimb.....
CrossRef
 
Google Scholar
 
 
Share
Send by email
RELATED ARTICLE
Skin and nasal vestibule colonisation by Staphylococcus aureus and its susceptibility to drugs in atopic dermatitis patients
The cause of Actinomyces canalictulis – a case study
Virulence and antibiotic resistance of Escherichia coli isolated from rooks
Antibiotic resistance of Escherichia coli isolated from a poultry slaughterhouse
Indexes
 
Keywords index
Topics index
Authors index
eISSN:1898-2263
ISSN:1232-1966
Journals System - logo
Improvement of editorial platform - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher Education allocated to the activities of disseminating science.

Improvement of visual identification of the journal - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher Education allocated to the activities of disseminating science.

Generation of the DOI (Digital Object Identifier) - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher
© 2006-2024 Journal hosting platform by Bentus
Scroll to top